Dr. Jay Shah has been appointed chief growth officer of Duo Health, a medical group focusing on patients with chronic and end-stage kidney disease.
Dr. Shah joins Duo Health from Babylon Health, where he served as managing director of growth. He also has experience as the managing director of new markets and growth for ChenMed, according to a Jan. 26 news release from Duo Health.
Dr. Shah has also held senior leadership positions at Lumeris, J.P. Morgan and GE Healthcare.